The global embolotherapy market is valued at USD 3.4 billion in 2021 and is expected to reach USD 5.0 billion by 2026, at a CAGR of 8.0% during the forecast period. The growth of this market is primarily driven by the rising burden of target diseases and increasing investments, funds, and grants for the development of novel products. Moreover, increasing demand for minimally invasive procedures, favorable reimbursement scenario, and new product launches in the market are further supporting the growth of the market over the forecast period. However, stringent regulatory frameworks for product commercialization and the strong market positioning of alternative treatments are expected to limit the optimal adoption of embolotherapy devices during the forecast period.
The cancer segment, by application, accounted for the largest share of the embolotherapy market in 2020 In terms of application, embolotherapy market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders.The high success rate and less post-operative complication rate associated with embolotherapy procedures coupled with the rising incidences of liver cancer and hepatocellular cancer are the key factors fueling the demand for embolotherapy devices for cancer disease indication.
For instance, liver cancer is the fifth most common cancer in men and the ninth most common in women.
The embolic agents segment, by product, is to register a significant growth rate owing to new product approvals Based on product, the embolotherapy market is broadly segmented into embolization coils (detachable coils and pushable coils), embolic agents (liquid embolic agents and microspheres), detachable balloons, embolic plug systems, and support devices (microcatheters and guidewires).The embolic agents segment is anticipated to register the highest growth over the forecast period owing to new product approvals and launches in the segment.
For instance, in 2019, Terumo received the FDA Premarket Approval (PMA) for the ‘WEB Aneurysm Embolization System.’ Moreover, in 2018, Medtronic launched OptiSphere embolization spheres in the US as well as the Concerto 3D detachable coil system in Ireland.
Increasing availability of reimbursements in most of developed countries to drive the segment growth of ambulatory surgical centers end user segment
Based on end users, the embolotherapy market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and other end users.The ambulatory surgery centers segment is projected to register the highest CAGR during the forecast period.
The significant growth of this segment can be attributed to the growing adoption of minimally invasive surgical procedures, the increasing number of procedures in ambulatory surgery centers, and the greater availability of reimbursements for target procedures in the US and major European countries.
The US market, by region, commanded the largest market share in 2020 On the basis of region, the embolotherapy market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.The US held the major share of the global embolotherapy market in 2018.
Factors such as the favorable reimbursement scenario in the US, growing target patient population (CVDs, neurovascular diseases, cancer, and uterine fibroids), increasing preference for minimally invasive procedures, new product launches and technological advancements in embolotherapy devices, and the presence of key players in the region are driving the growth of the embolotherapy market in the US.
A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1–45%, Tier 2–34%, and Tier 3– 21% • By Designation: C-level–47%, Director-level–33%, and Others–20% • By Region: North America–35%, Europe–32%, Asia Pacific–25%, Latin America–6%, and the Middle East & Africa–2%
Some of the prominent players in the embolotherapy market Boston Medical Corporation (US), Terumo Medical Systems (Japan), Medtronic (US), Johnson & Johnson (US), and Stryker Corporation (US). Other key players in the embolization therapy market include Sirtex Medical Limited (US), Abbott Laboratories (US), Acandis GmbH (Germany), Balt (France), Cook Medical (US), Kaneka Corporation (Japan), Penumbra, Inc. (US), Merit Medical Systems (US), Meril Life Sciences Pvt. Ltd. (India), Cardiva (US), Shape Memory Medical Inc. (US), Artio Medical Inc. (US), Rapid Medical (US), Emboline, Inc. (US), and IMbiotechnologies Ltd. (Canada), among others.
Research Coverage This report studies the embolotherapy market based on product, procedure, application, end user, and region.It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders.
Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the embolotherapy market • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the embolotherapy market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the embolotherapy market • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Our reports have been used by over 10K customers, including:
The manufacturing execution system market is expected to grow from USD 11.5 billion in 2021 to USD 17.1 billion by 2026 at a CAGR of 8.3% from 2021 to 2026. A few key factors driving the growth of this market include increasing use of industrial automation in process and discrete industries, increasing IT and OT convergence, and the need for...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Antimicrobial Medical Device Market Report
The global antimicrobial medical device coatings market by revenue is expected to grow at a CAGR of over 7% during the period 2021–2026.
The antimicrobial medical device coatings market constitutes...
The global medical device contract manufacturing market is estimated to reach USD 113.3 billion in 2026 from USD 65.9 billion in 2021, at a CAGR of 11.5% during the forecast period. The key factors driving the growth of the medical device contract manufacturing market include the overall growth of the medical devices market, mainly due to...
The disposable medical device sensors market is projected to reach USD 9.4 billion by 2026 from USD 6.5 billion in 2021, at a CAGR of 7.7% during the forecast period. Market growth is largely driven by rising concerns over hospital-acquired infections and contamination, the increasing incidence of target conditions, the growing demand for...
The global diagnostic imaging market is projected to reach USD 35.0 billion by 2026 from USD 26.6 billion in 2020, at a CAGR of 5.7% from 2021 to 2026. The growth of this market is primarily driven by the increasing demand for early disease diagnosis and widening scope of clinical applications, rapidly growing geriatric population and the...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The nitinol medical devices market was valued at US$ 15,807.53 million in 2020 and is projected to reach US$ 27,327.25 million by 2028; it is expected to grow at a CAGR of 7.08% during 2020-2028. The growth of the market is mainly attributed to the factors such as the increasing adoption of minimally invasive surgeries (MIS) and growing prevalence...
The implementation of track and trace solutions and technologies is an important strategy adopted by many manufacturing companies and regulatory bodies in recent years. The global track and trace solutions market is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period. Growth...
The 3D Printing Medical Devices market is projected to reach USD 5.1 billion by 2026 from USD 2.4 billion in 2021, at a CAGR of 16.3% during the forecast period. Growth of the market is mainly attributed to technological advancements; growing public and private investments and funding are driving the global 3D Printing Medical Devices market....
- Increase your foothold in the Chinese market TODAY - Establish partnerships to manufacture, distribute or develop Chinese products - Scope out the market prior to entry The China medical devices Market section gives a detailed market overview, qualitative analysis of the factors responsible for driving and restraining...
Medical Devices Sales
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.